GlassScriptPhysician profile
Lindsey Jackson Hathaway
NPI 1124461306
$785.50
in general payments reported to CMS, 2019-2025
19 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.24 · 2020: $40.10 · 2021: $39.73 · 2022: $227 · 2023: $80.24 · 2024: $118 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $178.82 | 2020-2025 | Enhertu, Lynparza, Imfinzi |
| Incyte Corporation | $95.65 | 2021-2024 | Jakafi, Monjuvi |
| Genentech USA, INC. | $95.48 | 2019-2025 | Itovebi, Polivy, Tecentriq Hybreza |
| Novartis Pharmaceuticals Corporation | $50.45 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $43.30 | 2019 | |
| Amgen INC. | $36.90 | 2022-2023 | Nplate, Vectibix, Xgeva |
| Cti Biopharma Corp. | $29.11 | 2022 | |
| Glaxosmithkline, LLC. | $28.05 | 2022 | |
| Abbvie INC. | $28.03 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $27.99 | 2022 | |
| Emd Serono, INC. | $22.06 | 2025 | |
| Eisai INC. | $22.03 | 2022 | |
| Epizyme, INC. | $21.40 | 2022 | |
| Morphosys, US INC. | $21.24 | 2021 | |
| Merck Sharp & Dohme LLC | $20.43 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.36 | 2022 | |
| Genmab U.S., INC. | $16.73 | 2024 | Epkinly |
| Pfizer INC. | $14.63 | 2019 | |
| Astellas Pharma US INC | $12.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Hathaway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.